NCT06342011 Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease
| NCT ID | NCT06342011 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
| Condition | Inflammatory Bowel Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2024-04-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
For the first time, this study developed an anti-inflammatory diet （AID） recipe suitable for Inflammatory bowel disease（IBD） patients and developed an AID application program to verify the intervention effect of AID on IBD patients, which not only promoted the application of AID in IBD patients and promoted the promotion of AID model, but also provided new ideas for the prevention and treatment strategies for IBD patients.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of inflammatory bowel disease, the diagnostic criteria refer to the 2018 revised Consensus opinion on the diagnosis and treatment of inflammatory bowel disease; 2. The patient has clear consciousness and certain understanding, language expression and writing ability; 3. Patients participated in this study knowingly and voluntarily; 4. At least 18 years old. Exclusion Criteria: 1. cognitive impairment, mental illness, accompanied by mental disorders; 2. Alcohol and drug abusers. 3. The patient could not participate in the researcher due to the deterioration of the condition; 4. Patients who voluntarily quit due to other reasons; 5. Those who did not complete the assessment scale during the experiment.
Contact & Investigator
Xia Qian, BA
PRINCIPAL INVESTIGATOR
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Frequently Asked Questions
Who can join the NCT06342011 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06342011 currently recruiting?
Yes, NCT06342011 is actively recruiting participants. Contact the research team at 1632936247@qq.com for enrollment information.
Where is the NCT06342011 trial being conducted?
This trial is being conducted at Yiwu, China.
Who is sponsoring the NCT06342011 clinical trial?
NCT06342011 is sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. The principal investigator is Xia Qian, BA at The Fourth Affiliated Hospital of Zhejiang University School of Medicine. The trial plans to enroll 88 participants.